Ketamine (Spravato®) Treatment
for Treatment-Resistant Depression
MindBridge Mental Health offers ketamine treatment using Spravato® (esketamine) for adults experiencing treatment-resistant depression — when standard antidepressant medications have not provided adequate symptom relief.
Spravato® is FDA-approved, commonly covered by insurance, and administered in a private, medically supervised setting. Appointments are available in-office, with scheduling conveniently offered online.
Our approach is thoughtful, supportive, and personalized. If you are considering ketamine treatment and want to understand whether it may be appropriate for your symptoms, we invite you to schedule a free 15-minute phone consultation to ensure we are a good fit.
Get support now.
What Is Ketamine (Spravato®) Treatment?
Spravato® is a prescription nasal spray containing esketamine, a form of ketamine approved for adults with treatment-resistant depression. It works differently than traditional antidepressants by targeting the glutamate system, which may allow some individuals to experience symptom improvement more quickly.
Because of its unique effects, Spravato® is only provided at certified treatment centers and is administered under medical supervision to support safety and comfort.
How We Treat Symptoms with Ketamine Therapy
We understand that depression affects each person differently. Our approach to ketamine treatment is individualized, structured, and closely monitored.
Your care plan may include:
- A comprehensive psychiatric evaluation
- Supervised Spravato® treatment sessions in a calm, private setting
- Ongoing symptom monitoring and follow-up care
- Coordination with therapy, medication management, and supportive treatments when appropriate
Ketamine treatment is often used alongside other mental health supports, such as therapy or medication, to help manage symptoms more effectively and improve overall functioning.
Our goal is to support symptom reduction while prioritizing safety, comfort, and long-term mental health stability.
What to Expect from Spravato® Treatment
Initial Evaluation
Your first appointment typically lasts about 60 minutes. During this visit, we will:
- Review your mental health history and previous treatments
- Discuss current symptoms and treatment goals
- Determine whether ketamine (Spravato®) treatment is appropriate
- Review potential benefits, side effects, and next steps
Treatment Sessions
Spravato® is administered as a nasal spray during scheduled in-office visits. After dosing, you will remain in our office for at least two hours so our clinical team can monitor your response and ensure your safety.
Common short-term effects may include:
- Drowsiness or relaxation
- Lightheadedness
- Temporary dissociation or altered perception
- Mild nausea or headache
These effects typically resolve before you leave the clinic. Because of these temporary effects, patients must arrange transportation home after each session.
Ongoing Care
Follow-up appointments usually last 15–30 minutes, depending on your treatment plan. We regularly assess symptoms, response to treatment, and whether adjustments are needed.
Insurance & Pricing
Insurance Accepted
We currently accept:
Payment Options:
We accept: Credit and debit cards | FSA and HSA cards
Appoitments
Appointments may be canceled or rescheduled 24 hours in advance without charge. We use HIPAA-compliant texting and email to simplify communication.
Ongoing Care
Follow-up appointments usually last 15–30 minutes, depending on your treatment plan. We regularly assess symptoms, response to treatment, and whether adjustments are needed.
Why Choose MindBridge Mental Health for Ketamine Treatment?
Common Symptoms We Address
Ketamine (Spravato®) Treatment FAQs
Learn about common mental health conditions